Journal Articles

• Chari, A., Rodriguez-Otero, P., McCarthy, H., Suzuki, K., Hungria, V., Sureda Balari, A., Perrot, A., Hulin, C., Magen, H., Iida, S., Maisnar, V., Karlin, L., Pour, L., Parasrampuria, D.A., Masterson, T., Kosh, M., Yang, S., Delioukina, M., Qi, M., Carson, R., Touzeau, C., 2021. Subcutaneous daratumumab plus standard treatment regimens in patients with multiple myeloma across lines of therapy (PLEIADES): an open-label Phase II study. British Journal of Haematology, 192 (5), 869-878.
  • more information
  • view in BU repository
• Barr, P.M., Robak, T., Owen, C., Tedeschi, A., Bairey, O., Bartlett, N.L., Burger, J.A., Hillmen, P., Coutre, S., Devereux, S., Grosicki, S., McCarthy, H., Li, J., Simpson, D., Offner, F., Moreno, C., Zhou, C., Styles, L., James, D., Kipps, T.J., Ghia, P., 2018. Sustained efficacy and detailed clinical follow-up of first-line ibrutinib treatment in older patients with chronic lymphocytic leukemia: Extended phase 3 results from RESONATE-2. Haematologica, 103 (9), 1502-1510.
  • more information
  • view in BU repository